Endothelial Beta 1-integrins in Cerebral Vascular Barrier Integrity

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Abstract

Ischemic stroke acutely targets the cerebral microvasculature. Within hours following proximal MCA occlusion, the microvessel endothelial permeability barrier opens causing ?vasogenic? edema in the corpus striatum. This process is not fully understood and has no treatment currently. Cerebral microvessel structure and signaling appears central to these acute changes. Interfering with the established adhesion of endothelial cell ?1- integrins to the underlying matrix acutely increases T2 but not ADC by 14T MRI within 6 hours, and acutely increases permeability in vitro, alters tight junction (TJ) expression, and alters F-actin conformation, without loss of endothelial cell viability. However, inhibition of myosin light chain (MLC) phosphorylation, within 6 hours in vitro, prevents the permeability increase when established ?1-integrin?matrix adhesion is disrupted. Hence, modulating endothelial ?1-integrin signaling acutely could preserve the barrier and decrease striatal edema. The hypotheses to be tested in this proposal state that i) interactions of microvessel endothelial cells with their basal lamina matrix proteins through ?1-integrin adhesion receptors are a major structural and signaling determinant of blood-brain barrier behavior, ii) focal ischemia disrupts stable ?1-integrin?matrix interactions, iii) disruption of these interactions increases microvessel permeability, and iv) this acutely increased permeability and edema can be prevented by inhibiting ?1-integrin signaling. The three Specific Aims will demonstrate that: 1) rapid modulation of the MLC and associated ?1-integrin signaling can prevent the acute permeability increase caused by interference with ?1-integrin?matrix adhesion, 2) experimental ischemia disrupts endothelial cell ?1-integrin?matrix adhesion, induces endothelial signaling that increases permeability, and this can be prevented, and 3) focal ischemia, through tissue injury, decreases ?1-integrin expression or matrix adhesion, and increases endothelial permeability, which can be prevented. A central role for endothelial cell ?1-integrin?matrix adhesion as the determinant of acute ?vasogenic? edema in focal ischemia is conceptually novel and testable. With high-quality primary cerebral endothelial cell cultures from wild type and conditional endothelial ?1-integrin knockout constructs to define ?1-integrin signaling events (Specific Aim 1), in vitro models to quantify the effects of ischemia on endothelial cell ?1-integrin signaling (Specific Aim 2), and real- time assessment of acute edema formation in murine stereotaxic injection and MCA occlusion models using real-time 14T MRI to guide acute assessments of permeability and its prevention with signaling inhibitors (Specific Aims 1 and 3), this Project will demonstrate that ?1-integrin?matrix adhesion is pivotal to edema prevention. These very feasible studies are a new direction in stroke research that will substantially further our understanding of acute blood-brain barrier behavior under focal ischemia. Understanding ?1-integrin signaling mechanisms is also likely to identify novel specific targets to preserve or selectively change endothelial barrier function in other neurovascular disorders, with the aim to improve outcome.